Cryopreservation of Ovarian Cortex in Girls With Turner Syndrome
CRYO-X0
1 other identifier
interventional
47
1 country
1
Brief Summary
Ovarian insufficiency is common in Turner syndrome related to premature and rapid follicular apoptosis and spontaneous pregnancies are rare in this population. Ovarian cryopreservation has been used in an effort to preserve fertility in patients undergoing treatments which lead to premature and severe ovarian insufficiency. This study aims to assess the relevance of ovarian tissue cryopreservation in girls with Turner syndrome. Based on ovarian follicular density as primary outcome and karyotypic, clinical and hormonal markers as secondary outcomes, analysis of the study will allow to select the patients to whom the procedure would benefit the most.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 28, 2011
CompletedFirst Posted
Study publicly available on registry
August 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 16, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2031
ExpectedMarch 30, 2026
March 1, 2026
3 years
June 28, 2011
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the ovarian follicular density
the specific measure is the ovarian follicular density which will allow to Identify criteria, to predict existence or absence of ovarian follicles at the time of the surgery
at the time of the ovariectomy
Secondary Outcomes (1)
measure hormonal markers
Before the ovariectomy, 1 month and 12 months after the ovariectomy
Study Arms (1)
Surgery
EXPERIMENTALOvariectomy
Interventions
Ovarian cryopreservation has been used in an effort to preserve fertility in patients undergoing treatments which lead to premature and severe ovarian insufficiency.
Eligibility Criteria
You may qualify if:
- girls aged from 1 to 25 years included,
- with Turner syndrome or mosaic
- patients aged more than 18 will only have ovarian insufficiency dated less than 5 years
- without any severe disease, particularly of cardiovascular type
- whose agreement to participate to the study has been signed by the parents
- whose agreement to participate to the study has been signed by majority age patient
You may not qualify if:
- girls aged less than one year and over 25 years old
- if any surgery would be contra-indicated
- ovary alone presence
- Well-known infection by HIV, and/or HBV, and/or HCV and/or syphilis TPHA VDRL
- No social coverage affiliate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- URC-CIC Paris Descartes Necker Cochincollaborator
- Assistance Publique - Hôpitaux de Parislead
- Groupe Hospitalier Pitie-Salpetrierecollaborator
Study Sites (1)
Hopital Bicêtre
Le Kremlin-Bicêtre, 94275, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lise Duranteau, MD, PhD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2011
First Posted
August 4, 2011
Study Start
January 1, 2011
Primary Completion
January 16, 2014
Study Completion (Estimated)
February 1, 2031
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share